Literature DB >> 10559326

Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

P E Tam1, R P Messner.   

Abstract

Enterovirus infection and persistence have been implicated in the pathogenesis of certain chronic muscle diseases. In vitro studies suggest that persistent enteroviruses mutate, evolving into forms that are less lytic and display altered tropism, but it is less clear whether these mechanisms operate in vivo. In this study, persistent coxsackievirus RNA from the muscle of mice afflicted with chronic inflammatory myopathy (CIM) was characterized and compared with RNA from a virus that had established a persistent infection of G8 mouse myoblasts for 30 passages in vitro. Competitive strand-specific reverse transcription-PCR and susceptibility to RNase I treatment revealed that plus- and minus-strand viral RNAs were present at nearly equivalent levels in muscle and that they persisted in a double-stranded conformation. All regions of the viral genome persisted and were amplified as a series of seven overlapping fragments. Restriction endonuclease fingerprinting coupled with sequencing indicated that there was no evolution of the viral genome associated with its persistence in muscle. This contrasted with the productive persistent infection that was established in myoblast cultures, where plus-strand RNA predominated and persistent virus developed distinct mutations. In vitro persistence proceeded by a carrier culture mechanism and was completely dependent on production of infectious virus, since persistent viral RNA was not detected in cultures subjected to antibody-mediated curing. These experiments demonstrate that persistence of coxsackievirus RNA in muscle is not facilitated by distinct genetic changes in the virus that give rise to replication-defective forms but occurs primarily through production of stable double-stranded RNA that is produced as the acute viral infection resolves. The data suggest a mechanism for coxsackievirus persistence in myofibers and perhaps other nondividing cells whereby cells that survive infection could harbor persistent viral RNA for extended times without producing detectable levels of infectious virus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559326      PMCID: PMC113063     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Modified tissue pulverization technique and evaluation of dihydrofolate reductase amplification as a pan-tissue RT PCR control.

Authors:  P E Tam; A M Schmidt; R P Messner
Journal:  PCR Methods Appl       Date:  1993-08

Review 2.  When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

Authors:  B L Jacobs; J O Langland
Journal:  Virology       Date:  1996-05-15       Impact factor: 3.616

3.  AmpliTaq DNA polymerase, FS dye-terminator sequencing: analysis of peak height patterns.

Authors:  L T Parker; H Zakeri; Q Deng; S Spurgeon; P Y Kwok; D A Nickerson
Journal:  Biotechniques       Date:  1996-10       Impact factor: 1.993

4.  Restriction endonuclease fingerprinting (REF): a sensitive method for screening mutations in long, contiguous segments of DNA.

Authors:  Q Liu; S S Sommer
Journal:  Biotechniques       Date:  1995-03       Impact factor: 1.993

5.  Denervated segments of injured skeletal muscle fibers are reinnervated by newly formed neuromuscular junctions.

Authors:  J Rantanen; J Ranne; T Hurme; H Kalimo
Journal:  J Neuropathol Exp Neurol       Date:  1995-03       Impact factor: 3.685

6.  Genetic determinants of susceptibility to coxsackievirus B1-induced chronic inflammatory myopathy: effects of host background and major histocompatibility complex genes.

Authors:  P E Tam; R P Messner
Journal:  J Lab Clin Med       Date:  1996-09

7.  Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome.

Authors:  I Leparc-Goffart; J Julien; F Fuchs; I Janatova; M Aymard; H Kopecka
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 8.  Are cytokines associated with neuropsychiatric syndromes in humans?

Authors:  I Hickie; A Lloyd
Journal:  Int J Immunopharmacol       Date:  1995-08

9.  Persistence of enterovirus RNA in muscle biopsy samples suggests that some cases of chronic fatigue syndrome result from a previous, inflammatory viral myopathy.

Authors:  N E Bowles; T A Bayston; H Y Zhang; D Doyle; R J Lane; L Cunningham; L C Archard
Journal:  J Med       Date:  1993

10.  Sequences specific for enterovirus detected in spinal cord from patients with motor neurone disease.

Authors:  C J Woodall; M H Riding; D I Graham; G B Clements
Journal:  BMJ       Date:  1994-06-11
View more
  48 in total

1.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 2.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

3.  Retrograde axonal transport: a major transmission route of enterovirus 71 in mice.

Authors:  Che-Szu Chen; Yi-Chuan Yao; Shin-Chao Lin; Yi-Ping Lee; Ya-Fang Wang; Jen-Ren Wang; Ching-Chuan Liu; Huan-Yao Lei; Chun-Keung Yu
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 4.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy.

Authors:  Nicolas Lévêque; Fanny Renois; Déborah Talmud; Yohan Nguyen; François Lesaffre; Camille Boulagnon; Patrick Bruneval; Paul Fornes; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2012-07-25       Impact factor: 5.948

6.  Coxsackievirus B3 mutator strains are attenuated in vivo.

Authors:  Nina F Gnädig; Stéphanie Beaucourt; Grace Campagnola; Antonio V Bordería; Marta Sanz-Ramos; Peng Gong; Hervé Blanc; Olve B Peersen; Marco Vignuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-01       Impact factor: 11.205

7.  Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.

Authors:  S P Deshpande; S Lee; M Zheng; B Song; D Knipe; J A Kapp; B T Rouse
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 8.  Pancreatic pathology in type 1 diabetes mellitus.

Authors:  Sarah J Richardson; Noel G Morgan; Alan K Foulis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

9.  Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1.

Authors:  S J Richardson; P Leete; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2012-10-14       Impact factor: 10.122

10.  Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4.

Authors:  Daniel M Potvin; Dennis W Metzger; William T Lee; Doris N Collins; Arlene I Ramsingh
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.